CoChat

CD153/CD30 signaling promotes age-dependent tertiary lymphoid tissue expansion and kidney injury

Open access
Sato, Yuki, Oguchi, Akiko, Fukushima, Yuji, Masuda, Kyoko, Toriu, Naoya, Taniguchi, Keisuke, Yoshikawa, Takahisa, Cui, Xiaotong, Kondo, Makiko, Hosoi, Takeshi, Komidori, Shota, Shimizu, Yoko, Fujita, Harumi, Jiang, Li, Kong, Yingyi, Yamanashi, Takashi, Seita, Jun, Yamamoto, Takuya, Toyokuni, Shinya, Hamazaki, Yoko, Hattori, Masakazu, Yoshikai, Yasunobu, Boor, Peter, Floege, Jürgen, Kawamoto, Hiroshi, Murakawa, Yasuhiro, Minato, Nagahiro, Yanagita, Motoko · 2022 · Journal of Clinical Investigation
Cited by 109

The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.

Abstract

Tertiary lymphoid tissues (TLTs) facilitate local T and B cell interactions in chronically inflamed organs. However, the cells and molecular pathways that govern TLT formation are poorly defined. Here, we identified TNF superfamily CD153/CD30 signaling between 2 unique age-dependent lymphocyte subpopulations, CD153+PD-1+CD4+ senescence-associated T (SAT) cells and CD30+T-bet+ age-associated B cells (ABCs), as a driver for TLT expansion. SAT cells, which produced ABC-inducing factors IL-21 and IFN-γ, and ABCs progressively accumulated within TLTs in aged kidneys after injury. Notably, in kidney injury models, CD153 or CD30 deficiency impaired functional SAT cell induction, which resulted in reduced ABC numbers and attenuated TLT formation with improved inflammation, fibrosis, and renal function. Attenuated TLT formation after transplantation of CD153-deficient bone marrow further supported the importance of CD153 in immune cells. Clonal analysis revealed that SAT cells and ABCs in the kidneys arose from both local differentiation and recruitment from the spleen. In the synovium of aged rheumatoid arthritis patients, T peripheral helper/T follicular helper cells and ABCs also expressed CD153 and CD30, respectively. Together, our data reveal a previously unappreciated function of CD153/CD30 signaling in TLT formation and propose targeting the CD153/CD30 signaling pathway as a therapeutic target for slowing kidney disease progression.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1172/jci146071

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 22 references

Cited by

See all 109

Metadata

Authors
Sato, Y., Oguchi, A., Fukushima, Y., Masuda, K., Toriu, N., Taniguchi, K., Yoshikawa, T., Cui, X., Kondo, M., Hosoi, T., Komidori, S., Shimizu, Y., Fujita, H., Jiang, L., Kong, Y., Yamanashi, T., Seita, J., Yamamoto, T., Toyokuni, S., Hamazaki, Y., Hattori, M., Yoshikai, Y., Boor, P., Floege, J., Kawamoto, H., Murakawa, Y., Minato, N., & Yanagita, M.
Venue
Journal of Clinical Investigation
Published
2022-01-18
Volume
132
Issue
2
ISSN
  • 0021-9738 (ISSN-L)
  • 1558-8238
OpenAlex
W3217220006
Cited by
109
References
22
FWCI
4.61
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: CD153/CD30 signaling promotes age-dependent tertiary lymphoid tissue expansion and kidney injury. https://app.cochat.ai/papers/10.1172/jci146071
The paper
Sato, Y., Oguchi, A., Fukushima, Y., Masuda, K., Toriu, N., Taniguchi, K., Yoshikawa, T., Cui, X., Kondo, M., Hosoi, T., Komidori, S., Shimizu, Y., Fujita, H., Jiang, L., Kong, Y., Yamanashi, T., Seita, J., Yamamoto, T., Toyokuni, S., . . . Yanagita, M. (2022). CD153/CD30 signaling promotes age-dependent tertiary lymphoid tissue expansion and kidney injury. Journal of Clinical Investigation. https://doi.org/10.1172/jci146071

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.